Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I21RX003483-01 |
| Title: | Genetic Associations with Hearing Loss from Cancer Treatment |
| Principal Investigator: | Dawn L. Konrad-Martin |
| Location: | Portland, OR |
| Congressional District Code: | 3 |
| Research Service: | Rehabilitation R&D |
| Project Period: | August 2020 - July 2022 |
| FY 2021 Funding Amount: | $97,039 |
| Total Award Amount (all years): |
$199,868 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Approximately 1 in 3 Americans will be diagnosed with cancer in their lifetime (IOM, 2006). Within VA last year alone, an estimated 10,421 patients received platinum-based chemotherapy with cisplatin [2,443], carboplatin [5,621], or oxaliplatin [2357] (VA Cancer Registry, 2018). These are common treatments for myriad cancers (Rybak, 2007; Miaskowski et al., 2018; Sogaard et al., 2013) and are known to cause lasting damage to the ear [ototoxic]. The reported incidence of sensorineural hearing los... |